Relugolix
340 interactions 260 explained in plain English 125 cited referencesRelugolix is a gonadotropin-releasing hormone receptor antagonist used to treat advanced prostate cancer in adult men. Read the full Relugolix drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Relugolix Bacillus Of Calmette And Guerin Vaccine, Live Explained An increased risk of infection by the live vaccine Details Relugolix Bepridil Explained An increased risk of QT interval prolongation Details Relugolix Cisapride Propulsid® Explained Increased risk of QT interval prolongation Details Relugolix Dengue Tetravalent Vaccine, Live Explained An increased risk of infection by the live vaccine Details Relugolix Dronedarone Multaq Explained Increased relugolix exposure and an increased risk of QT interval prolongation Details Relugolix Levoketoconazole Recorlev Explained An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Relugolix Measles Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details Relugolix Mesoridazine Explained An increased risk of QT interval prolongation Details Relugolix Mumps Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details Relugolix Pimozide Explained An increased risk of QT interval prolongation Details Relugolix Piperaquine Explained An increased risk of QT interval prolongation Details Relugolix Ranolazine Aspruzyo Explained Reduced ranolazine exposure, increased relugolix exposure and an increased risk of QT interval prolongation Details Relugolix Rubella Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details Relugolix Saquinavir Explained An increased risk of QT interval prolongation Details Relugolix Smallpox Monkeypox Vaccine Explained An increased risk of infection by the live vaccine Details Relugolix Sparfloxacin Explained An increased risk of QT interval prolongation Details Relugolix Terfenadine Explained An increased risk of QT interval prolongation Details Relugolix Thioridazine Explained An increased risk of QT interval prolongation Details Relugolix Typhoid Vaccine Typhim VI® Explained An increased risk of infection by the live vaccine Details Relugolix Varicella Virus Vaccine, Live Explained An increased risk of infection by the live vaccine Details Relugolix Yellow Fever Vaccine Stamaril Explained An increased risk of infection by the live vaccine Details Relugolix Ziprasidone Geodon Explained An increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist